CoChat

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

Open access
McCowan, C, Shearer, J, Donnan, P T, Dewar, J A, Crilly, M, Thompson, A M, Fahey, T P · 2008 · British Journal of Cancer

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Increasing duration of tamoxifen therapy improves survival in women with breast cancer but the impact of adherence to tamoxifen on mortality is unclear. This study investigated whether women prescribed tamoxifen after surgery for breast cancer adhered to their prescription and whether adherence influenced survival. A retrospective cohort study of all women with incident breast cancer in the Tayside region of Scotland between 1993 and 2002 was linked to encashed prescription records to calculate adherence to tamoxifen. Survival analysis was used to determine the effect of adherence on all-cause mortality. In all 2080 patients formed the study cohort with 1633 (79%) prescribed tamoxifen. The median duration of use was 2.42 years (IQR=1.04-4.89 years). Longer duration was associated with better survival but this varied over time. The hazard ratio for mortality in relation to duration at 2.4 years was 0.85, 95% CI=0.83-0.87. Median adherence to tamoxifen was 93% (interquartile range=84-100%). Adherence <80% was associated with poorer survival, hazard ratio 1.10, 95% CI=1.001-1.21. Persistence with tamoxifen was modest with only 49% continuing therapy for 5 years of those followed up for 5 years or more. Increased duration of tamoxifen reduces the risk of death, although one in two women do not complete the recommended 5-year course of treatment. A significant proportion of women have low adherence to tamoxifen and are at increased risk of death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6604758

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Calculation of adherence and duration.
Figure 1 Calculation of adherence and duration.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 1

  1. Early Breast Cancer Trialists’ Collaborative Group (2004) Tamoxifen for early breast cancer. Cochrane Database of Systematic Reviews, Reviews 2008 Issue 4. John Wiley & Sons, Ltd.: Chichester, UK

Cited by

See all 381

Metadata

Authors
McCowan, C., Shearer, J., Donnan, P. T., Dewar, J. A., Crilly, M., Thompson, A. M., & Fahey, T. P.
Affiliations
  • University of Dundee (GB)
  • University of Aberdeen (GB)
  • Royal College of Surgeons in Ireland (IE)
Corresponding author
McCowan, C
Venue
British Journal of Cancer
Published
2008-11-04
Volume
99
Issue
11
Pages
1763-1768
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2139442403
Cited by
343
References
32
Citations by year
2026: 11 · 2025: 14 · 2024: 10 · 2023: 17 · 2022: 22 · 2021: 20 · 2020: 19 · 2019: 20 · 2018: 20 · 2017: 22 · 2016: 20 · 2015: 25 · 2014: 21 · 2013: 32 · 2012: 27
FWCI
10.16
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
Funders
  • University of Dundee
  • NHS Health Scotland
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
tamoxifen, medication adherence, breast cancer, all-cause mortality, survival, treatment persistence, adjuvant endocrine therapy, prescription records
MeSH terms
Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Humans, Middle Aged, Retrospective Studies, Tamoxifen, Cohort Studies, Drug Monitoring, Chemotherapy, Adjuvant, Selective Estrogen Receptor Modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. https://app.cochat.ai/papers/10.1038/sj.bjc.6604758
The paper
McCowan, C., Shearer, J., Donnan, P. T., Dewar, J. A., Crilly, M., Thompson, A. M., & Fahey, T. P. (2008). Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6604758

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.